iNOS-derived NO may play a protective role against the progression to NASH during an HFD by preventing fibrosis and inflammation, which are mediated by NF-kB activation in Kupffer cells. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.